These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21793419)

  • 1. [Selective serotonin reuptake inhibitors (SSRI) and osteoporosis].
    Fétique-Will AC; Chevalley T; Rizzoli R
    Rev Med Suisse; 2011 Jun; 7(299):1299-304. PubMed ID: 21793419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women.
    Saraykar S; John V; Cao B; Hnatow M; Ambrose CG; Rianon N
    J Clin Densitom; 2018; 21(2):193-199. PubMed ID: 28712980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
    Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.
    Seifert CF; Wiltrout TR
    Clin Ther; 2013 Sep; 35(9):1412-7. PubMed ID: 23958172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
    Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
    Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.
    Bruyère O; Reginster JY
    Endocrine; 2015 Feb; 48(1):65-8. PubMed ID: 25091520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
    Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
    Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective serotonin reuptake inhibitors on the risk of fracture.
    Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D;
    Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased risk of osteoporosis following treatment with SSRI?].
    Sondell M; Dahlqvist R
    Lakartidningen; 2008 Sep 3-9; 105(36):2426-7. PubMed ID: 18831455
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.
    Ak E; Bulut SD; Bulut S; Akdağ HA; Öter GB; Kaya H; Kaya OB; Şengül CB; Kısa C
    Osteoporos Int; 2015 Jan; 26(1):273-9. PubMed ID: 25187118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adverse skeletal effects of selective serotonin reuptake inhibitors.
    Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
    Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective serotonin reuptake inhibitors on markers of bone loss.
    Kumar M; Jiloha RC; Kataria D; Prasad S; Vohora D
    Psychiatry Res; 2019 Jun; 276():39-44. PubMed ID: 31003023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition status, bone mass density, and selective serotonin reuptake inhibitors.
    Kindilien S; Goldberg EM; Roberts MH; Gonzales-Pacheco D
    Prev Med; 2018 Aug; 113():62-67. PubMed ID: 29746975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.
    Wu Q; Bencaz AF; Hentz JG; Crowell MD
    Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS).
    Moura C; Bernatsky S; Abrahamowicz M; Papaioannou A; Bessette L; Adachi J; Goltzman D; Prior J; Kreiger N; Towheed T; Leslie WD; Kaiser S; Ioannidis G; Pickard L; Fraser LA; Rahme E
    Osteoporos Int; 2014 May; 25(5):1473-81. PubMed ID: 24566587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health.
    Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.
    Calarge CA; Ellingrod VL; Zimmerman B; Bliziotes MM; Schlechte JA
    J Clin Psychiatry; 2011 Dec; 72(12):1685-90. PubMed ID: 22244026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?
    Weaver SR; Hernandez LL
    J Mammary Gland Biol Neoplasia; 2018 Jun; 23(1-2):5-25. PubMed ID: 29603039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
    Haney EM; Warden SJ; Bliziotes MM
    Bone; 2010 Jan; 46(1):13-7. PubMed ID: 19664737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.